Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT06790966 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06790966
Sponsor: PDS Biotechnology Corp.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Head and Neck Cancer Metastatic Head and Neck Cancer HPV Positive Oropharyngeal Squamous Cell Carcinoma Neoplasms, Head and Neck Unresectable Head and Neck Squamous Cell Carcinoma

Start date: 2025-05-30
Primary completion: 2029-02-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.